233 related articles for article (PubMed ID: 35192601)
1. Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.
Harrison GF; Leaton LA; Harrison EA; Kichula KM; Viken MK; Shortt J; Gignoux CR; Lie BA; Vukcevic D; Leslie S; Norman PJ
PLoS Comput Biol; 2022 Feb; 18(2):e1009059. PubMed ID: 35192601
[TBL] [Abstract][Full Text] [Related]
2. Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.
González-Quezada BA; Sánchez-Fernández MGJ; Munguía-Saldaña AJ; Valencia-Macedo ME; Flores-Aguilar H; Bonilla-Galán E; Rodríguez-Gómez A; Díaz-Rivera A; Gorodezky C
Hum Immunol; 2018 Dec; 79(12):834-838. PubMed ID: 30365992
[TBL] [Abstract][Full Text] [Related]
3. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
[TBL] [Abstract][Full Text] [Related]
4. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
[TBL] [Abstract][Full Text] [Related]
5. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.
Norman PJ; Abi-Rached L; Gendzekhadze K; Korbel D; Gleimer M; Rowley D; Bruno D; Carrington CV; Chandanayingyong D; Chang YH; Crespí C; Saruhan-Direskeneli G; Fraser PA; Hameed K; Kamkamidze G; Koram KA; Layrisse Z; Matamoros N; Milà J; Park MH; Pitchappan RM; Ramdath DD; Shiau MY; Stephens HA; Struik S; Verity DH; Vaughan RW; Tyan D; Davis RW; Riley EM; Ronaghi M; Parham P
Nat Genet; 2007 Sep; 39(9):1092-9. PubMed ID: 17694054
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
[TBL] [Abstract][Full Text] [Related]
7. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
[TBL] [Abstract][Full Text] [Related]
8. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
[TBL] [Abstract][Full Text] [Related]
9. A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.
Pontikos N; Smyth DJ; Schuilenburg H; Howson JM; Walker NM; Burren OS; Guo H; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Jayaraman J; Jiang W; Traherne JA; Trowsdale J; Todd JA; Wallace C
BMC Genomics; 2014 Apr; 15():274. PubMed ID: 24720548
[TBL] [Abstract][Full Text] [Related]
10. KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.
Taniguchi M; Kawabata M
Immunogenetics; 2009 Dec; 61(11-12):717-30. PubMed ID: 19859704
[TBL] [Abstract][Full Text] [Related]
11. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.
Erer B; Takeuchi M; Ustek D; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Duymaz-Tozkir J; Gül A; Kastner DL; Remmers EF; Ombrello MJ
Genes Immun; 2016 Dec; 17(7):396-399. PubMed ID: 27708262
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
[TBL] [Abstract][Full Text] [Related]
14. Allelic diversity of KIR3DL1/3DS1 in a southern Chinese population.
Deng Z; Zhen J; Zhu B; Zhang G; Yu Q; Wang D; Xu Y; He L; Lu L
Hum Immunol; 2015 Sep; 76(9):663-6. PubMed ID: 26416088
[TBL] [Abstract][Full Text] [Related]
15. Contribution of functional KIR3DL1 to ankylosing spondylitis.
Zvyagin IV; Mamedov IZ; Britanova OV; Staroverov DB; Nasonov EL; Bochkova AG; Chkalina AV; Kotlobay AA; Korostin DO; Rebrikov DV; Lukyanov S; Lebedev YB; Chudakov DM
Cell Mol Immunol; 2010 Nov; 7(6):471-6. PubMed ID: 20818412
[TBL] [Abstract][Full Text] [Related]
16. KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.
Jiang Y; Chen O; Cui C; Zhao B; Han X; Zhang Z; Liu J; Xu J; Hu Q; Liao C; Shang H
BMC Infect Dis; 2013 Sep; 13():405. PubMed ID: 24059286
[TBL] [Abstract][Full Text] [Related]
17. The profile of KIR3DL1 and KIR3DS1 alleles in an African American population resembles that found in African populations.
Jiang B; Hou L; Chen M; Ng J; Hurley CK
Tissue Antigens; 2010 Jul; 76(1):64-6. PubMed ID: 20230527
[TBL] [Abstract][Full Text] [Related]
18. High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.
Koehler RN; Walsh AM; Moqueet N; Currier JR; Eller MA; Eller LA; Wabwire-Mangen F; Michael NL; Robb ML; McCutchan FE; Kijak GH
Tissue Antigens; 2009 Jul; 74(1):73-80. PubMed ID: 19522772
[TBL] [Abstract][Full Text] [Related]
19. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
[TBL] [Abstract][Full Text] [Related]
20. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
Boudreau JE; Giglio F; Gooley TA; Stevenson PA; Le Luduec JB; Shaffer BC; Rajalingam R; Hou L; Hurley CK; Noreen H; Reed EF; Yu N; Vierra-Green C; Haagenson M; Malkki M; Petersdorf EW; Spellman S; Hsu KC
J Clin Oncol; 2017 Jul; 35(20):2268-2278. PubMed ID: 28520526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
